Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 50.1 EUR -3.28%
Market Cap: 4.5B EUR

Intrinsic Value

The intrinsic value of one AFX stock under the Base Case scenario is 79.87 EUR. Compared to the current market price of 50.1 EUR, Carl Zeiss Meditec AG is Undervalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AFX Intrinsic Value
79.87 EUR
Undervaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Carl Zeiss Meditec AG

AFX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AFX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Carl Zeiss Meditec AG
XETRA:AFX
DE
Health Care
Market Cap
4.4B EUR
IPO
Mar 20, 2000
DE
Health Care
Market Cap
4.4B EUR
IPO
Mar 20, 2000
Price
€false
EPS
€false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AFX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Carl Zeiss Meditec AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carl Zeiss Meditec AG

Current Assets 1.2B
Cash & Short-Term Investments 39.5m
Receivables 582.9m
Other Current Assets 590m
Non-Current Assets 2.2B
Long-Term Investments 20.4m
PP&E 353.8m
Intangibles 1.7B
Other Non-Current Assets 117.2m
Efficiency

Free Cash Flow Analysis
Carl Zeiss Meditec AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Carl Zeiss Meditec AG

Revenue
2.1B EUR
Cost of Revenue
-993.4m EUR
Gross Profit
1.1B EUR
Operating Expenses
-909.3m EUR
Operating Income
179m EUR
Other Expenses
-21.9m EUR
Net Income
157m EUR
Fundamental Scores

AFX Profitability Score
Profitability Due Diligence

Carl Zeiss Meditec AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
53/100
Profitability
Score

Carl Zeiss Meditec AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

AFX Solvency Score
Solvency Due Diligence

Carl Zeiss Meditec AG's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
63/100
Solvency
Score

Carl Zeiss Meditec AG's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AFX Price Targets Summary
Carl Zeiss Meditec AG

Wall Street analysts forecast AFX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFX is 63.38 EUR with a low forecast of 50.5 EUR and a high forecast of 94.5 EUR.

Lowest
Price Target
50.5 EUR
1% Upside
Average
Price Target
63.38 EUR
27% Upside
Highest
Price Target
94.5 EUR
89% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AFX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one AFX stock?

The intrinsic value of one AFX stock under the Base Case scenario is 79.87 EUR.

Is AFX stock undervalued or overvalued?

Compared to the current market price of 50.1 EUR, Carl Zeiss Meditec AG is Undervalued by 37%.

Back to Top